Showing results (361-370 of 495) with videos related to
Sort By:
Pageof 50
Die Rehabilitation|March 31, 2017
[Rehabilitation Processes in Out- and Inpatient Rehabilitation after Radical Prostatectomy]H M Rath, A Ullrich, U Otto, et al.Biochemistry|May 19, 1992
Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activitiesM Kellerer, R Lammers, B Ermel, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1994
One bead, one chemical compound: use of the selectide process for anticancer drug discoveryS E Salmon, K S Lam, S Felder, et al.Structure (London, England : 1993)|November 15, 1994
Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2D Kohda, H Terasawa, S Ichikawa, et al.The Journal of Biological Chemistry|February 5, 1987
Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulinC K Chou, T J Dull, D S Russell, et al.The EMBO Journal|October 1, 1988
Biological activities of EGF-receptor mutants with individually altered autophosphorylation sitesA Honegger, T J Dull, F Bellot, et al.The EMBO Journal|November 1, 1989
Phospholipase C-gamma, a substrate for PDGF receptor kinase, is not phosphorylated on tyrosine during the mitogenic response to CSF-1J R Downing, B L Margolis, A Zilberstein, et al.Molecular Endocrinology (Baltimore, Md.)|March 1, 1988
Defects in human insulin receptor gene expressionK Ojamaa, J A Hedo, C T Roberts, et al.International Journal of Cancer|September 9, 1992
Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cellsC Marth, T Lang, M V Cronauer, et al.International Journal of Cancer|March 15, 1990
Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissuesP G Natali, M R Nicotra, A Bigotti, et al.Pageof 50